Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Identification of HIV integrase inhibitor BMS-727740 described by Bristol-Myers Squibb

Aug. 30, 2010

LIM-0705 reverses tacrolimus-induced metabolic defects in phase Ib trial

Aug. 27, 2010

DIDS improves yield and preserves integrity of isolated pancreatic islets

Aug. 27, 2010

NGP-328 is selected as clinical candidate for Alzheimer's disease

Aug. 27, 2010

Researchers describe new anti-inflammatory MAPK 14 inhibitors

Aug. 27, 2010

Netupitant shows promise to treat overactive bladder in preclinical studies

Aug. 27, 2010

New adenosylhomocysteinase inhibitors show preclinical potential to treat AD

Aug. 26, 2010

Scientists present preclinical data on new HCV NS4A antagonists at ACS meeting

Aug. 26, 2010

New SGLT-2 inhibitor CSG-452 is selected as clinical candidate

Aug. 26, 2010

SAR-106881, an FGFR agonist derived from FGFR antagonists

Aug. 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...